Costa Mesa, CA, United States of America

Frank A Lehmkuhl


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovator Frank A. Lehmkuhl: A Pioneer in Antiviral Nucleosides

Introduction

Frank A. Lehmkuhl, based in Costa Mesa, CA, is a notable inventor primarily recognized for his contributions to the field of antiviral compounds. With a focused background in pharmaceutical innovation, Lehmkuhl's research and inventions play a crucial role in the ongoing battle against viral infections.

Latest Patents

Lehmkuhl holds a patent for a significant invention titled "5-Hydroxyl-1,2,3-triazole-4-carboxamide nucleoside." This innovative nucleoside, related to the C-nucleoside pyrazomycin, presents a facile synthesis method through the condensation of acyl-blocked ribofuranose with trimethylsilylated 5-hydroxy-1,2,3-triazole-4-carboxamide. Alternatively, it can be synthesized via cycloaddition involving a suitably blocked β-D-ribofuranosyl azide and the anion of ethyl malonamate. The potential of this invention is highlighted by its demonstrated antiviral properties, marking a promising avenue in antiviral agent development. Additionally, the patent also discloses a triazole precursor and certain novel salts as potential antiviral agents.

Career Highlights

Throughout his career, Lehmkuhl has been dedicated to advancing pharmaceutical science. His work at Icn Pharmaceuticals, Inc. reflects a commitment to developing impactful therapeutic solutions. The success of his patent showcases his innovative approach and expertise in synthesizing compounds that could enhance antiviral treatments.

Collaborations

Lehmkuhl collaborated with esteemed colleagues such as Joseph T. Witkowski and Roland K. Robins. These partnerships further exemplify the collaborative spirit prevalent in the research and development community, as they work collectively towards pioneering advancements in health and medicine.

Conclusion

Frank A. Lehmkuhl stands out as a significant inventor in the pharmaceutical industry, focusing on antiviral nucleosides that hold promise for future therapeutic applications. His contributions not only reflect individual ingenuity but also underline the importance of collaboration in scientific advancements. The potential impact of his inventions may pave the way for new antiviral strategies, benefiting public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…